Wednesday, July 31, 2024

Sponsored Content by Jen Mallia for the Globe and Mail*

The healthcare industry is ripe for transformation, and some of the key technologies advancing patient care are in progress right here in Canada.

“Canada has long been a key player on the world stage of innovation, surrounded by diverse and ambitious talent – nowhere is this more prevalent than in the healthcare industry,” says Najah Sampson, president of Pfizer Canada.

Last year, Pfizer launched the Healthcare Hub Call for Solutions, a program to accelerate solutions by local innovators to address some of the most pressing healthcare challenges in Canada.

“We have the opportunity to mobilize our combined strengths and talents to help deliver for patients in Canada and around the world,” Sampson says.

Designed to support founders in developing, manufacturing and scaling their products, the $1.4-million of funding and in-kind support that includes access to industry insights and internal expertise.

“We know that fostering this type of innovation environment goes beyond dollars – it includes prioritizing new ideas, collaboration, and research and development, so that Canada can be a leader in addressing patient needs,” Sampson says.

The first cohort of three winners will see made-in-Canada solutions that aim to help improve immunization uptake, transform the drug coverage process, and increase the speed of breast cancer diagnosis and effectiveness of tumor monitoring.

To read more from the Globe and Mail on the Pfizer Canada Healthcare Hub, visit here. 

*Advertising feature produced by Globe Content Studio with Pfizer Canada. The Globe’s editorial department was not involved.